Incidence, persistence, and clinical relevance of iatrogenic atrial septal defects after percutaneous left atrial appendage occlusion.
Dominik NellesVivian VijBaravan Al-KassouMarcel WeberJohanna VogelhuberThomas BeiertGeorg NickenigJan Wilko SchrickelAlexander SedaghatPublished in: Echocardiography (Mount Kisco, N.Y.) (2021)
After a median of 92 days (IQR 75-108 days) after LAAO, 50 patients (50/144, 34.7%) showed evidence of an iASD. Patients with iASD had higher CHADS-VASc-scores (4.9±1.5 vs 4.2±1.2, p = 0.03), larger left atrial volumes (80.5±30.5 ml vs 67.1±19.7 ml, p = 0.01) and were more likely to have relevant mitral regurgitation (≥° II) (46.0% vs 12.3%, p = 0.001). LAAO procedures took longer (50.1±24.3 vs 41.1±17.8 min, p = 0.06) in patients with a persisting iASD. Furthermore, larger device sizes were implanted (24.3±3.4 mm vs 22.1±2.8 mm, p = 0.03). The presence of an iASD had no impact on RV dysfunction, thromboembolism or mortality. Spontaneous closure of an iASD was documented in 52.0% (26/50). Hereby, similar risk factors were identified for the persistence of an iASD in follow-up.
Keyphrases
- atrial fibrillation
- left atrial
- left atrial appendage
- risk factors
- catheter ablation
- end stage renal disease
- newly diagnosed
- mitral valve
- ejection fraction
- mycobacterium tuberculosis
- chronic kidney disease
- peritoneal dialysis
- heart failure
- type diabetes
- cardiovascular events
- prognostic factors
- oxidative stress
- ultrasound guided
- coronary artery disease
- cardiovascular disease